Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2012
Ramaswamy Govindan, M.D.
Molecular Assay to Predict Outcomes in Resected NSCLC using Nanostring Technolog
Read More
2012
Steven Zeitels, M.D., FACS
Voice Preservation in the Treatment of Early Glottic (Laryngeal) Cancer
Read More
2012
Hai Yan, M.D., Ph.D.
Supplemental SPORE Developing Novel Approaches to Target Gliomas
Read More
2012
Susan Goodin, PharmD.
Prevention of Prostate Cancer progression by atorvastatin and celecoxib
Read More
2012
Peter Forsyth, M.D.
Developing Myxoma Virus as an Experimental Treatment for Brain Cancer Stem Cells...
Read More
2012
Corrine Linardic, M.D., Ph.D.
Understanding SFRP’s contribution to alveolar rhabdomyosarcoma tumorigenesis
Read More
2012
Daniel S. Wechsler, M.D., Ph.D.
Strike While the Iron is Not:  Targeting CALM-Rearranged Leukemias by Iron Deprivation
Read More
2012
St. Helena Hospital Foundation
Caring for the Future
Read More
2012
Nehal Parikh, M.D.
Isolation and Characterization of Cancer Stem Cells in Neuroblastoma Tumor Model
Read More
2012
All Children’s Hospital
N/A
Read More
2012
James M. Ford, M.D.
N/A
Read More
2012
MD Anderson Cancer Center
N/A
Read More
2012
Angela M. Hartley Brodie, Ph.D.
Targeting Mechanisms of Resistance to Hormone Therapy in Breast Cancer
Read More
2012
Ian Davis, M.D., Ph.D.
Targeting Deregulated Transcription in Pediatric Cancers
Read More
2012
Steven P. Balk, M.D., Ph.D., Huihui Ye, MMSc., Glenn Bubley, M.D., Martin Sanda, M.D.
Molecular characterization of Gleason 3 tumors that progress to Gleason 4
Read More
2012
W. Kimryn Rathmell, M.D., Ph.D., Jason Lieb, Ph.D., Ian Davis, M.D., Ph.D.
Reprogramming the Histone Methylation Code of Renal Cell Carcinoma
Read More